Optimal assessment and management of chronic obstructive pulmonary disease (COPD). The European Respiratory Society Task Force
NM Siafakas(University of Crete), al et(Université Ibn-Tofail), J C Yernault(University of Crete), Jack Gibson(Nottingham City Hospital), N.B. Pride(University of Crete), P. Vermeire(University Hospital Foundation), Tim Higenbottam(AstraZeneca (United Kingdom)), DS Postma(University of Crete), P Howard(Royal Hallamshire Hospital), Marc Decramer(KU Leuven), P Paoletti(University of Crete)
Cited by 1,593
Related Papers
Withdrawal of Inhaled Glucocorticoids and Exacerbations of COPD
|New England Journal of Medicine|2014|621
Interstitial Lung Disease in Japanese Patients with Lung Cancer
|American Journal of Respiratory and Critical Care Medicine|2008|488
High Doses of Vitamin D to Reduce Exacerbations in Chronic Obstructive Pulmonary Disease
|Annals of Internal Medicine|2012|362
Incidence of Chronic Obstructive Pulmonary Disease in a Cohort of Young Adults According to the Presence of Chronic Cough and Phlegm
|American Journal of Respiratory and Critical Care Medicine|2006|308
Asthma control in Europe: A real-world evaluation based on an international population-based study
|Journal of Allergy and Clinical Immunology|2007|276